Yan, Q. and Liu, J. (2025) “Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome/chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies”, Haematologica. Pavia, Italy, 110(5), p. 1236. doi: 10.3324/haematol.2024.287052.